HDAC9 and neoplasm: A recent study showed that both the HDAC inhibitor ACY-1215 and a small molecule inhibitor of the MITF pathway (ML329) were able to reduce the proliferation of a metastatic UM cell line in vitro and caused regression of tumours derived from this cell line in zebrafish, but did not influence tumour dissemination [189].